With an attrition rate of up to 95% for oncology drug development, it is evident that significant barriers still exist when it comes to translating preclinical investigation findings to in-human trials.
This new Guide from TransCure bioServices explores how humanized mouse models can help accelerate the successful development of novel, safe, and effective treatments for oncology by generating human-relevant data.
We examine:
- The types of mouse model available
- The role and application of humanized mouse models in immuno-oncology research
- How to select the most appropriate model for your specific needs
- The benefits of partnering with a preclinical CRO specialising in humanized mouse models
